TISSUEBLUE

Manufacturer
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. | Pharmpur GmbH
Effective date
2026-04-17
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-05-31 22:15:35

Label at a glance#

ProductTISSUEBLUE
Active ingredientBRILLIANT BLUE G
Label structure14 sections

Storage and handling

TissueBlue (Brilliant Blue G Ophthalmic Solution), 0.025% is supplied as 0.5 mL of Brilliant Blue G Ophthalmic Solution, 0.025% in a sterile, single-dose Luer Lok, 2.25 mL glass syringe, with a grey rubber plunger stopper and tip cap with polypropylene plunger rod in a pre-formed polypropylene blister pouch sealed with a Tyvek® lid. NDC 68803-722-05 (One 0.5 mL syringe) NDC 68803-722-25 (Carton of five 0.5 mL syri...

Label contents#

Full prescribing information#

Indications & Usage

INDICATIONS & USAGE SECTION

TissueBlue 0.025% is indicated to selectively stain the internal limiting membrane (ILM).

Dosage & Administration 

DOSAGE & ADMINISTRATION SECTION

TissueBlue 0.025% is carefully injected into the Balanced Salt Solution (BSS)-filled vitreous cavity using a blunt cannula attached to the pre-filled syringe, without allowing the cannula to contact the retina or allowing TissueBlue to get under the retina. Sufficient staining is expected within a few seconds. Following staining, all excess dye should be removed from the vitreous cavity.

Dosage forms & Strengths 

DOSAGE FORMS & STRENGTHS SECTION

TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is a clear, bright blue, single-dose ophthalmic solution supplied in 2.25 mL syringes pre-filled to a volume of 0.5 mL.

Contraindications 

CONTRAINDICATIONS SECTION

None

Warnings and Precautions 

WARNINGS AND PRECAUTIONS SECTION

Excessive Staining
Excess TissueBlue 0.025% should be removed from the eye immediately after staining.

Use of the Syringe
Make sure the plunger moves smoothly before injecting the solution. Do not use the product if the plunger does not move smoothly to prime the cannula.

Adverse Reactions 

ADVERSE REACTIONS SECTION

Adverse reactions that have been reported in procedures that included the use of Brilliant Blue G Ophthalmic Solution have often been associated with the surgical procedure. These complications include retinal (retinal break, tear, hemorrhage, and detachment) and cataracts.

Use in specific populations 

USE IN SPECIFIC POPULATIONS SECTION

Pregnancy

PREGNANCY SECTION

Risk Summary
There are no available data on the use of TissueBlue 0.025% in pregnant women to inform a drug associated risk. Systemic absorption of TissueBlue 0.025% in humans is expected to be negligible following intravitreal injection and subsequent removal of the drug at the completion of surgical procedures. Due to the negligible systemic exposure, it is not expected that maternal use of TissueBlue 0.025% will result in fetal exposure to the drug.


Adequate animal reproduction studies were not conducted with TissueBlue 0.025%.

Lactation

LACTATION SECTION

Risk Summary
No data are available regarding the presence of Brilliant Blue G in human milk after intraocular administration of TissueBlue 0.025%, or the effects on the breastfed infant or the effects on milk production. However, breastfeeding is not expected to result in exposure of the child to Brilliant Blue G due to the expected negligible systemic exposure of BBG in humans following intravitreal injection and subsequent removal of the drug at the completion of surgical procedures.

Pediatric use

PEDIATRIC USE SECTION

The safety and effectiveness of TissueBlue 0.025% in pediatric patients has not been established.

Geriatric use

GERIATRIC USE SECTION

No overall differences in safety or effectiveness were observed between elderly and younger adult patients.

Description

DESCRIPTION SECTION

TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is a sterile solution of BBG (a dye) for intraocular ophthalmic use. Each mL of TissueBlue 0.025% contains BBG 0.25 mg, polyethylene glycol and buffered sodium chloride solution (sodium chloride, dibasic sodium phosphate, monobasic sodium phospage, water for injection). Phosphoric acid and/or sodium hydroxide may also be used for pH adjustment. The pH range of TissueBlue 0.025% Solution is between 7.3 and 7.6.


The drug substance BBG has the chemical name Brilliant Blue G, a molecular weight of 854.02 and has the following chemical structure:

Molecular formula: C 47H 48N 3NaO 7S 2

BBG.jpgBBG.jpg

Clinical Pharmacology

CLINICAL PHARMACOLOGY SECTION

Mechanism of action

MECHANISM OF ACTION SECTION

Brilliant Blue G has been shown to selectively stain the ILM, but not the epiretinal membrane nor the retina, making it easier to visualize the membrane for removal, although the exact mechanism of this selectivity has not been elucidated.

Nonclinical toxicology

NONCLINICAL TOXICOLOGY SECTION

Nonclinical toxicology

NONCLINICAL TOXICOLOGY SECTION

Studies to evaluate the potential for carcinogenicity or impairment of fertility of TissueBlue 0.025% have not been conducted.
Brilliant Blue G was not mutagenic in the Ames assay, the in vitro mouse lymphoma assay, or the in vivo rat micronucleus assay.

How Supplied/Storage and Handling

HOW SUPPLIED SECTION

TissueBlue (Brilliant Blue G Ophthalmic Solution), 0.025% is supplied as 0.5 mL of Brilliant Blue G Ophthalmic Solution, 0.025% in a sterile, single-dose Luer Lok, 2.25 mL glass syringe, with a grey rubber plunger stopper and tip cap with polypropylene plunger rod in a pre-formed polypropylene blister pouch sealed with a Tyvek® lid.


NDC 68803-722-05 (One 0.5 mL syringe)
NDC 68803-722-25 (Carton of five 0.5 mL syringes)

How Supplied/Storage and Handling

STORAGE AND HANDLING SECTION

TissueBlue 0.025% should be stored at 15°C to 25°C (59°F to 77°F). Protect from light, frost and moisture.

SPL UNCLASSIFIED SECTION

Manufactured for D.O.R.C., Dutch Ophthalmic Research Center (International) B.V., Zuidland, 3214 VN, The Netherlands

Made in Germany

All trademarks are the property of their respective owners.

Package Label - 0.5 mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TissueBlue

(Brilliant Blue G Ophthalmic Solution) 0.025%

Staining Solution for Ophthalmic Surgery

Protect from light, frost and moisture. Store at 15°C to 25°C (59°F to 77°F). Sterile.

Active ingredients: Brilliant Blue G 0.025% Inactive ingredients: Water for injection, Sodium chloride, dibasic sodium phosphate, monobasic sodium phosphate, polyethylene glycol, phosphoric acid and/or sodium hydroxide may also be used for pH adjustment.

NDC 68803-722-05 (One 0.5 mL syringe)
NDC 68803-722-25 (Carton of five 0.5 mL syringes)

carton.jpgcarton.jpg

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BRILLIANT BLUE G Pharmacologic Class Indexing1Indexing - Pharmacologic Class20230404

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
a7d4b4db-013e-463b-a016-c04dc0b3d6a2Product name120200604
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68803-722-05TISSUEBLUE1 in 1 POUCHINJECTION, SOLUTION18
68803-722-05TISSUEBLUE10 in 1 CARTONINJECTION, SOLUTION108

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68803-722-05ML - Milliliter68803-7224ba0d135-eeaf-425e-bd6f-477c5c218c9012020-08-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68803-72268803-722-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N209569-001TISSUEBLUEBRILLIANT BLUE G0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 1 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N209569-001ODE-2822026-12-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20c2088c7a36db…
2026-09-14 22:38:342026-08N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-2084e616aacf4f…
2026-08-18 06:07:402026-07N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-204b0b4de00fa7…
2022-03-09 01:35 UTC2022-03N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-2087673890dc5c…
2021-03-12 10:30 UTC2021-03N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-205aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-208869cabd3fbd…
2020-11-12 02:37 UTC2020-11N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20c0c555d07b60…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-206a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-201c564ffb4f44…
2023-12-20 04:57 UTC2023-12N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-209b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-203f0d92c62455…
2023-05-13 08:27 UTC2023-05N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20053a50430f4f…
2023-01-26 05:58 UTC2023-01N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-203bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-203a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N209569-001TISSUEBLUE0.025%SOLUTION / OPHTHALMICRLD, RS2019-12-20a50c72e98297…

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 2 · 71 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-10-15 13:18:302026-09N209569-001ODE-2822026-12-20c2088c7a36db…
2026-09-14 22:38:342026-08N209569-001ODE-2822026-12-2084e616aacf4f…
2026-08-18 06:07:402026-07N209569-001ODE-2822026-12-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N209569-001ODE-2822026-12-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N209569-001ODE-2822026-12-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08N209569-001ODE-2822026-12-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N209569-001ODE-2822026-12-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N209569-001ODE-2822026-12-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209569-001NCE2024-12-2003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209569-001ODE-2822026-12-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209569-001NCE2024-12-202680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209569-001ODE-2822026-12-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209569-001NCE2024-12-205bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209569-001ODE-2822026-12-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209569-001NCE2024-12-20d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209569-001ODE-2822026-12-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N209569-001NCE2024-12-20d06236e962d9…
2024-10-29 15:01 UTC2024-10N209569-001ODE-2822026-12-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N209569-001NCE2024-12-2079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N209569-001ODE-2822026-12-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N209569-001NCE2024-12-20301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N209569-001ODE-2822026-12-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N209569-001NCE2024-12-201e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N209569-001ODE-2822026-12-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05N209569-001NCE2024-12-208072bd15b7f6…
2024-05-31 18:47 UTC2024-05N209569-001ODE-2822026-12-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N209569-001NCE2024-12-205c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N209569-001ODE-2822026-12-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N209569-001NCE2024-12-205d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N209569-001ODE-2822026-12-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N209569-001NCE2024-12-204b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N209569-001ODE-2822026-12-204b0b4de00fa7…
2022-03-09 01:35 UTC2022-03N209569-001NCE2024-12-20bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N209569-001ODE-2822026-12-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N209569-001NCE2024-12-20782e0a99824c…
2021-12-28 21:50 UTC2021-12N209569-001ODE-2822026-12-20782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N209569-001NCE2024-12-2087673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N209569-001ODE-2822026-12-2087673890dc5c…
2021-03-12 10:30 UTC2021-03N209569-001NCE2024-12-205aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N209569-001ODE-2822026-12-205aa47cf7b7d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TISSUEBLUEBRILLIANT BLUE GD.O.R.C. Dutch Ophthalmic Research Center (International) B.V.9d4b28b4-c582-4e2c-abd9-f7e203378e2d2026-04-17Warnings, Adverse reactionsExact identifier
ndc (package): 68803-722-05
ndc (product): 68803-722
ndc11 (package): 68803072205
spl id: 4fa75b7a-9ebf-72e1-e063-6294a90a2565
spl set id: 9d4b28b4-c582-4e2c-abd9-f7e203378e2d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.